Allurion Technologies(US:ALUR)2026-03-30 12:30Financial Performance and Condition - The company had cash and cash equivalents totaling $5.4 million as of December 31, 2025, primarily invested in money market funds[586]. - The company had no variable rate debt outstanding as of December 31, 2025, indicating a stable debt profile[587]. - The cash out value of the company's convertible notes is $42.9 million as of December 31, 2025, which exceeds the cash available to the company[437]. - The fair value of the liability associated with the Public Warrants decreased from $13.8 million at the time of the Business Combination to $0.2 million by December 31, 2025[457]. - The fair value of the liability associated with the Earn-Out Shares was initially valued at $53.0 million but dropped to less than $0.1 million by December 31, 2025[458]. Stock and Shareholder Impact - The share price of the company experienced significant volatility in 2025, ranging from a high of $10.43 to a low of $1.13, with daily trading volumes fluctuating between approximately 8,300 and 74,451,700 shares[404]. - Future sales of common stock may lead to dilution of existing shareholders' ownership and could negatively impact the share price[410]. - The issuance of a substantial number of shares of common stock could lead to increased volatility and a decline in the market price of the company's common stock[444]. - In February 2025, the company issued 900,000 shares of common stock and accompanying warrants at an offering price of $5.23 per share, raising approximately $4.7 million[446]. - In November 2025, the company sold 2,994,012 shares of common stock and accompanying warrants at an offering price of $1.67 per share[448]. - As of March 17, 2026, the last quoted sale price for the company's common stock was $0.60 per share, indicating potential negative returns for public securityholders[450]. - As of March 17, 2026, there were 13,206,720 Public Warrants outstanding with an exercise price of $202.50 per share, which are currently "out of the money"[452]. Regulatory and Compliance Issues - The company faces increased costs and demands on management due to compliance with public company regulations, which may adversely affect its financial condition[411]. - The company may face increased legal and financial compliance costs due to changing laws and regulations, impacting its operational efficiency[413]. - The company is classified as an "emerging growth company," allowing it to take advantage of certain exemptions from disclosure requirements, potentially making its securities less attractive to investors[419]. - The company is classified as a "smaller reporting company," allowing it to take advantage of certain exemptions from disclosure requirements until its market value exceeds $250 million or annual revenue exceeds $100 million[422]. - The company has identified material weaknesses in its internal control over financial reporting, including insufficient segregation of duties and lack of experienced staff, which could affect the accuracy of financial results[424][425]. - The company is currently working to remediate these material weaknesses by hiring experienced staff and upgrading its enterprise resource planning system to SAP[426]. Capital and Funding Challenges - The company needs to raise additional capital to execute its business plan, which may not be available on favorable terms due to current market conditions[429]. - The company's public float is below $75 million, limiting its ability to raise capital through primary public offerings under the "baby shelf" rules[430][431]. - Trading of the company's securities on the NYSE was suspended due to failure to meet market capitalization standards, which could adversely impact investor perception and liquidity[432][436]. - The company has received delisting notices from the NYSE and is appealing these determinations, which could result in permanent delisting if unsuccessful[433][435]. Foreign Currency Risks - The company is exposed to foreign currency risks from transactions in currencies other than its functional currency, which may impact operating expenses[588]. - A 10% increase or decrease in current exchange rates could materially impact the company's business, financial condition, or results of operations[589]. - The primary exposure to foreign currency is in Europe, with additional exposure in the Middle East and Asia-Pacific regions[589]. - The company has not engaged in any foreign currency hedging activities to date[590]. - An immediate 10% adverse change in foreign exchange rates during the year ended December 31, 2025, would have impacted revenues by approximately 4% and expenses by 3%, affecting net loss by 2%[590]. - For the year ended December 31, 2024, a similar adverse change would have impacted revenues by approximately 6% and expenses by 3%, also affecting net loss by 2%[590]. Restructuring and Operational Challenges - The company implemented a strategic restructuring in August 2025, incurring costs of approximately $1.8 million primarily for one-time severance benefits[401]. - The company expects to incur unforeseen difficulties and costs from its restructuring efforts, which may disrupt operations and affect financial results[401].